These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 33151182)

  • 1. Genetic parkinsonisms and cancer: a systematic review and meta-analysis.
    Sturchio A; Dwivedi AK; Vizcarra JA; Chirra M; Keeling EG; Mata IF; Kauffman MA; Pandey MK; Roviello G; Comi C; Versino M; Marsili L; Espay AJ
    Rev Neurosci; 2021 Feb; 32(2):159-167. PubMed ID: 33151182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. When does postural instability appear in monogenic parkinsonisms? An individual-patient meta-analysis.
    Marsili L; Vizcarra JA; Sturchio A; Dwivedi AK; Keeling EG; Patel D; Mishra M; Farooqi A; Merola A; Fasano A; Mata IF; Kauffman MA; Espay AJ
    J Neurol; 2021 Sep; 268(9):3203-3211. PubMed ID: 32436106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of Hereditary and GBA1-Related Parkinsonism in Latin America: A Systematic Review and Meta-Analysis.
    Saffie Awad P; Teixeira-Dos-Santos D; Santos-Lobato BL; Camargos S; Cornejo-Olivas M; de Mello Rieder CR; Mata IF; Chaná-Cuevas P; Klein C; Schumacher Schuh AF
    Mov Disord; 2024 Jan; 39(1):6-16. PubMed ID: 37921246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Subthalamic Deep Brain Stimulation With Motor, Functional, and Pharmacologic Outcomes in Patients With Monogenic Parkinson Disease: A Systematic Review and Meta-analysis.
    Artusi CA; Dwivedi AK; Romagnolo A; Pal G; Kauffman M; Mata I; Patel D; Vizcarra JA; Duker A; Marsili L; Cheeran B; Woo D; Contarino MF; Verhagen L; Lopiano L; Espay AJ; Fasano A; Merola A
    JAMA Netw Open; 2019 Feb; 2(2):e187800. PubMed ID: 30707228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysis.
    Agalliu I; San Luciano M; Mirelman A; Giladi N; Waro B; Aasly J; Inzelberg R; Hassin-Baer S; Friedman E; Ruiz-Martinez J; Marti-Masso JF; Orr-Urtreger A; Bressman S; Saunders-Pullman R
    JAMA Neurol; 2015 Jan; 72(1):58-65. PubMed ID: 25401981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do polymorphisms in the familial Parkinsonism genes contribute to risk for sporadic Parkinson's disease?
    Sutherland GT; Halliday GM; Silburn PA; Mastaglia FL; Rowe DB; Boyle RS; O'Sullivan JD; Ly T; Wilton SD; Mellick GD
    Mov Disord; 2009 Apr; 24(6):833-8. PubMed ID: 19224617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The genetic landscape of Parkinson's disease.
    Lunati A; Lesage S; Brice A
    Rev Neurol (Paris); 2018 Nov; 174(9):628-643. PubMed ID: 30245141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New endemic familial parkinsonism in south Moravia, Czech Republic and its genetical background.
    Bartoníková T; Menšíková K; Kolaříková K; Vodička R; Vrtěl R; Otruba P; Kaiserová M; Vaštík M; Mikulicová L; Ovečka J; Šáchová L; Dvorský F; Krša J; Jugas P; Godava M; Bareš M; Janout V; Hluštík P; Procházka M; Kaňovský P
    Medicine (Baltimore); 2018 Sep; 97(38):e12313. PubMed ID: 30235682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of LRRK2 and SNCA in autosomal dominant Parkinson's disease in Turkey.
    Kessler C; Atasu B; Hanagasi H; Simón-Sánchez J; Hauser AK; Pak M; Bilgic B; Erginel-Unaltuna N; Gurvit H; Gasser T; Lohmann E
    Parkinsonism Relat Disord; 2018 Mar; 48():34-39. PubMed ID: 29248340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterodimerization of Lrrk1-Lrrk2: Implications for LRRK2-associated Parkinson disease.
    Dachsel JC; Nishioka K; Vilariño-Güell C; Lincoln SJ; Soto-Ortolaza AI; Kachergus J; Hinkle KM; Heckman MG; Jasinska-Myga B; Taylor JP; Dickson DW; Gibson RA; Hentati F; Ross OA; Farrer MJ
    Mech Ageing Dev; 2010 Mar; 131(3):210-4. PubMed ID: 20144646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease penetrance of late-onset parkinsonism: a meta-analysis.
    Trinh J; Guella I; Farrer MJ
    JAMA Neurol; 2014 Dec; 71(12):1535-9. PubMed ID: 25330418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digenic parkinsonism: investigation of the synergistic effects of PRKN and LRRK2.
    Dächsel JC; Mata IF; Ross OA; Taylor JP; Lincoln SJ; Hinkle KM; Huerta C; Ribacoba R; Blazquez M; Alvarez V; Farrer MJ
    Neurosci Lett; 2006 Dec; 410(2):80-4. PubMed ID: 17095157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.
    Benitez BA; Davis AA; Jin SC; Ibanez L; Ortega-Cubero S; Pastor P; Choi J; Cooper B; Perlmutter JS; Cruchaga C
    Mol Neurodegener; 2016 Apr; 11():29. PubMed ID: 27094865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autosomal dominant Parkinson's disease: Incidence of mutations in LRRK2, SNCA, VPS35 and GBA genes in Brazil.
    Abreu GM; Valença DC; Campos M; da Silva CP; Pereira JS; Araujo Leite MA; Rosso AL; Nicaretta DH; Vasconcellos LF; da Silva DJ; Della Coletta MV; Dos Santos JM; Gonçalves AP; Santos-Rebouças CB; Pimentel MM
    Neurosci Lett; 2016 Dec; 635():67-70. PubMed ID: 27777137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent and fatal akinetic crisis in genetic-mitochondrial parkinsonisms.
    Bonanni L; Onofrj M; Valente EM; Manzoli L; De Angelis MV; Capasso M; Thomas A
    Eur J Neurol; 2014 Sep; 21(9):1242-6. PubMed ID: 24471704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monogenic Parkinson's disease and parkinsonism: clinical phenotypes and frequencies of known mutations.
    Puschmann A
    Parkinsonism Relat Disord; 2013 Apr; 19(4):407-15. PubMed ID: 23462481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Parkinson disease patients from Portugal for mutations in SNCA, PRKN, PINK1 and LRRK2.
    Bras J; Guerreiro R; Ribeiro M; Morgadinho A; Januario C; Dias M; Calado A; Semedo C; Oliveira C; Hardy J; Singleton A
    BMC Neurol; 2008 Jan; 8():1. PubMed ID: 18211709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C9ORF72 intermediate repeat expansion in patients affected by atypical parkinsonian syndromes or Parkinson's disease complicated by psychosis or dementia in a Sardinian population.
    Cannas A; Solla P; Borghero G; Floris GL; Chio A; Mascia MM; Modugno N; Muroni A; Orofino G; Di Stefano F; Calvo A; Moglia C; Restagno G; Meloni M; Farris R; Ciaccio D; Puddu R; Vacca MI; Melis R; Murru MR; Tranquilli S; Corongiu D; Rolesu M; Cuccu S; Marrosu MG; Marrosu F
    J Neurol; 2015 Nov; 262(11):2498-503. PubMed ID: 26275564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of gene discovery in Parkinson's disease and parkinsonism.
    Wider C; Foroud T; Wszolek ZK
    Mov Disord; 2010; 25 Suppl 1():S15-20. PubMed ID: 20187245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical genetics of Parkinson's disease and related disorders.
    Wider C; Wszolek ZK
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S229-32. PubMed ID: 18267241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.